0002149973-26-000004.txt : 20260902 0002149973-26-000004.hdr.sgml : 20260902 20260902172724 ACCESSION NUMBER: 0002149973-26-000004 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20260901 FILED AS OF DATE: 20260902 DATE AS OF CHANGE: 20260902 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Smith Margaret Ekins CENTRAL INDEX KEY: 0002149973 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39756 FILM NUMBER: 261356043 MAIL ADDRESS: STREET 1: C/O ARS PHARMACEUTICALS, INC. STREET 2: 11682 EL CAMINO REAL, SUITE 300 CITY: SAN DIEGO STATE: CA ZIP: 92130 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ARS Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001671858 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences EIN: 811489190 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 11682 EL CAMINO REAL, SUITE 300 CITY: SAN DIEGO STATE: CA ZIP: 92130 BUSINESS PHONE: 858-771-9307 MAIL ADDRESS: STREET 1: 11682 EL CAMINO REAL, SUITE 300 CITY: SAN DIEGO STATE: CA ZIP: 92130 FORMER COMPANY: FORMER CONFORMED NAME: Silverback Therapeutics, Inc. DATE OF NAME CHANGE: 20160412 4 1 form4-09022026_090920.xml X0609 4 2026-09-01 0001671858 ARS Pharmaceuticals, Inc. SPRY 0002149973 Smith Margaret Ekins false C/O ARS PHARMACEUTICALS, INC. 11682 EL CAMINO REAL, SUITE 300 SAN DIEGO CA 92130 false true false false Chief Commercial Officer 0 Stock Option (right to buy) 5.77 2026-09-01 4 A 0 1001738 0 A 2036-08-31 Common Stock 1001738 1001738 D 25% of the shares subject to the option vest on August 17, 2027, and the remaining shares will vest monthly thereafter over three years. /s/ Kathleen Scott, Attorney-in-Fact 2026-09-02